Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Christopher Chang, Atsushi Tanaka, Christopher Bowlus & M. Eric Gershwin. (2020) The use of biologics in the treatment of autoimmune liver disease. Expert Opinion on Investigational Drugs 29:4, pages 385-398.
Read now
Read now
Albert J Czaja. (2014) Current and prospective pharmacotherapy for autoimmune hepatitis. Expert Opinion on Pharmacotherapy 15:12, pages 1715-1736.
Read now
Read now
Albert J Czaja. (2012) Drug choices in autoimmune hepatitis: Part A – steroids. Expert Review of Gastroenterology & Hepatology 6:5, pages 603-615.
Read now
Read now
Albert J Czaja. (2012) Drug choices in autoimmune hepatitis: Part B – nonsteroids. Expert Review of Gastroenterology & Hepatology 6:5, pages 617-635.
Read now
Read now
Hind I Fallatah & Hisham O Akbar. (2011) Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy. Expert Review of Gastroenterology & Hepatology 5:4, pages 517-522.
Read now
Read now
Albert J Czaja. (2010) Animal models of autoimmune hepatitis. Expert Review of Gastroenterology & Hepatology 4:4, pages 429-443.
Read now
Read now
Articles from other publishers (40)
Madhumitha Rabindranath, Rita ZayaKhairunnadiya PrayitnoAni Orchanian-CheffKeyur PatelElmar JaeckelMamatha Bhat. (2023) A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis. Transplantation Direct 9:11, pages e1547.
Crossref
Crossref
Mirjam Kolev, Stefan Diem, Lara Diem, Susana G. Rodrigues, Annalisa Berzigotti, Guido Stirnimann & Nasser Semmo. (2022) Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis. Journal of Translational Autoimmunity 5, pages 100172.
Crossref
Crossref
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata & Shiv Kumar Sarin. (2021) The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatology International 15:2, pages 223-257.
Crossref
Crossref
Mohammadreza Abdollahi, Neda Khalilian Ekrami, Morteza Ghojazadeh, H Marike Boezen, Mohammadhossein Somi & Behrooz Z Alizadeh. (2020) Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?. World Journal of Gastroenterology 26:38, pages 5896-5910.
Crossref
Crossref
Neil Halliday, Jessica Katharine Dyson, Douglas Thorburn, Ansgar W. Lohse & Michael A. Heneghan. (2020) Review article: experimental therapies in autoimmune hepatitis. Alimentary Pharmacology & Therapeutics.
Crossref
Crossref
Feng‑Bin Lu, En‑De Hu Hu, Lan‑Man Xu, Yi‑Bing Hu, Lu Chen, Jin‑Lu Wu, Hui Li, Da‑Zhi Chen & Yong‑Ping Chen. (2018) Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta‑analysis. Experimental and Therapeutic Medicine.
Crossref
Crossref
Louis P. Voigt, Stephen M. Pastores & Neil A. Halpern. 2017. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set
437
444.e4
.
Seung Woon Park, Soon Ho Um, Han Ah Lee, Sang Hyun Kim, Yura Sim, Sun Young Yim, Yeon Seok Seo & Ho Sang Ryu. (2016) Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis. Clinical and Molecular Hepatology 22:2, pages 281-285.
Crossref
Crossref
K. Zachou, N. K. Gatselis, P. Arvaniti, S. Gabeta, E. I. Rigopoulou, G. K. Koukoulis & G. N. Dalekos. (2016) A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 43:10, pages 1035-1047.
Crossref
Crossref
Nicole MF van Gerven, Ynto S de Boer, Chris JJ Mulder, Carin MJ van Nieuwkerk & Gerd Bouma. (2016) Auto immune hepatitis. World Journal of Gastroenterology 22:19, pages 4651.
Crossref
Crossref
John M. Vierling. (2015) Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management. Clinical Gastroenterology and Hepatology 13:12, pages 2088-2108.
Crossref
Crossref
Farhad Sahebjam & John M. Vierling. (2015) Autoimmune hepatitis. Frontiers of Medicine 9:2, pages 187-219.
Crossref
Crossref
Zhihui Zhang, Ying Han, Jiangyuan Song, Ruxi Luo, Xin Jin, Dongdong Mu, Sha Su, Xiaoli Ji, Yan-Fang Ren & Hongwei Liu. (2015) Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity. Journal of Oral Pathology & Medicine 44:1, pages 15-27.
Crossref
Crossref
Nicole M. van Gerven, Sjoerd F. Bakker, Ynto S. de Boer, Birgit I. Witte, Hetty Bontkes, Carin M. van Nieuwkerk, Chris J. Mulder & Gerd Bouma. (2014) Seroprevalence of celiac disease in patients with autoimmune hepatitis. European Journal of Gastroenterology & Hepatology 26:10, pages 1104-1107.
Crossref
Crossref
K. Zachou, P. Muratori, G. K. Koukoulis, A. Granito, N. Gatselis, A. Fabbri, G. N. Dalekos & L. Muratori. (2013) Review article: autoimmune hepatitis - current management and challenges. Alimentary Pharmacology & Therapeutics 38:8, pages 887-913.
Crossref
Crossref
Albert J. Czaja. (2013) Hepatocellular Carcinoma and Other Malignancies in Autoimmune Hepatitis. Digestive Diseases and Sciences 58:6, pages 1459-1476.
Crossref
Crossref
Albert J. Czaja. (2013) Management of Recalcitrant Autoimmune Hepatitis. Current Hepatitis Reports 12:1, pages 66-77.
Crossref
Crossref
V. Selvarajah, A. J. Montano‐Loza & A. J. Czaja. (2012) Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Alimentary Pharmacology & Therapeutics 36:8, pages 691-707.
Crossref
Crossref
Joanna Vitfell-Pedersen, Marianne Hørby Jørgensen, Klaus Müller & Carsten Heilmann. (2012) Autoimmune Hepatitis in Children in Eastern Denmark. Journal of Pediatric Gastroenterology & Nutrition 55:4, pages 376-379.
Crossref
Crossref
Albert J. Czaja. (2012) Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis After Liver Transplantation. Digestive Diseases and Sciences 57:9, pages 2248-2266.
Crossref
Crossref
Albert J. Czaja. (2012) The Overlap Syndromes of Autoimmune Hepatitis. Digestive Diseases and Sciences.
Crossref
Crossref
Albert J. Czaja. (2012) Advances in the Current Treatment of Autoimmune Hepatitis. Digestive Diseases and Sciences 57:8, pages 1996-2010.
Crossref
Crossref
Albert J. Czaja. (2011) Autoantibody-Negative Autoimmune Hepatitis. Digestive Diseases and Sciences 57:3, pages 610-624.
Crossref
Crossref
John M. Vierling. (2011) Diagnosis and Treatment of Autoimmune Hepatitis. Current Gastroenterology Reports 14:1, pages 25-36.
Crossref
Crossref
Svein-Oskar Frigstad, Viggo Jønsson & Bjørn Moum. (2012) En kvinne i 60-årene med kombinert anemi. Tidsskrift for Den norske legeforening 132:8, pages 965-968.
Crossref
Crossref
Albert J. Czaja. 2012. Handbook of Liver Disease. Handbook of Liver Disease
70
94
.
Louis Voigt, Stephen M. Pastores & Neil A. Halpern. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
385
390.e3
.
Ghassan M. Hammoud & Jamal A. Ibdah. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
919
940
.
Hind I Fallatah & Hisham O Akbar. (2011) Autoimmune liver disease - are there spectra that we do not know?. Comparative Hepatology 10:1.
Crossref
Crossref
Albert J. Czaja. (2011) Autoimmune hepatitis in special patient populations. Best Practice & Research Clinical Gastroenterology 25:6, pages 689-700.
Crossref
Crossref
Albert J. Czaja. (2011) Cryptogenic Chronic Hepatitis and Its Changing Guise in Adults. Digestive Diseases and Sciences 56:12, pages 3421-3438.
Crossref
Crossref
Kalliopi Zachou, Nikolaos Gatselis, Georgia Papadamou, Eirini I. Rigopoulou & George N. Dalekos. (2011) Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. Journal of Hepatology 55:3, pages 636-646.
Crossref
Crossref
Albert J. Czaja. (2011) Drug-Induced Autoimmune-Like Hepatitis. Digestive Diseases and Sciences 56:4, pages 958-976.
Crossref
Crossref
Terreia S. Jones & Mary V. Relling. 2011. Pharmacogenomic Testing in Current Clinical Practice. Pharmacogenomic Testing in Current Clinical Practice
91
114
.
Luigi Muratori, Paolo Muratori, Alessandro Granito, Giorgios Pappas, Fabio Cassani & Marco Lenzi. (2010) Current topics in autoimmune hepatitis. Digestive and Liver Disease 42:11, pages 757-764.
Crossref
Crossref
Nikolaos K. Gatselis, Kalliopi Zachou, Panagiotis Papamichalis, George K. Koukoulis, Stella Gabeta, George N. Dalekos & Eirini I. Rigopoulou. (2010) Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: A new or a complementary diagnostic score?. Digestive and Liver Disease 42:11, pages 807-812.
Crossref
Crossref
Albert J. Czaja. (2010) Emerging Opportunities for Site-Specific Molecular and Cellular Interventions in Autoimmune Hepatitis. Digestive Diseases and Sciences 55:10, pages 2712-2726.
Crossref
Crossref
Albert J. Czaja & Michael P. Manns. (2010) Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis. Gastroenterology 139:1, pages 58-72.e4.
Crossref
Crossref
Albert J. Czaja. (2010) Late Relapse of Type 1 Autoimmune Hepatitis After Corticosteroid Withdrawal. Digestive Diseases and Sciences 55:6, pages 1761-1769.
Crossref
Crossref
Albert J. Czaja. 2010. GI/Liver Secrets. GI/Liver Secrets
132
141
.